Antimicrobial Resistance Patterns and Serological Diversity of <i>Shigella</i> Species from Patient Isolates at University Teaching Hospital in Lusaka, Zambia
Background: <i>Shigella</i> species are the leading cause of human shigellosis. In Zambia, more than 30% of children experiencing diarrhea are infected with <i>Shigella</i> species. The increasing resistance of <i>Shigella</i> species to the recommended therapy is...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Bacteria |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2674-1334/4/2/18 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Background: <i>Shigella</i> species are the leading cause of human shigellosis. In Zambia, more than 30% of children experiencing diarrhea are infected with <i>Shigella</i> species. The increasing resistance of <i>Shigella</i> species to the recommended therapy is of great concern. Therefore, this study investigated the antibiotic resistance profiles and phenotypic and genotypic characteristics of <i>Shigella</i> isolates at the largest referral hospital in Zambia. Methodology: Of the forty-eight archived presumptive <i>Shigella</i> isolates, thirty-two were serologically confirmed and subjected to antimicrobial susceptibility testing using the Kirby Bauer disk diffusion method. Thereafter, polymerase chain reaction was performed to detect the <i>bla</i> genes. Results: Most isolates were <i>Shigella flexneri</i> (16/32, 50%) and <i>Shigella sonnei</i> (14/32, 44%), while <i>Shigella boydii</i> and <i>Shigella dysenteriae</i> were rare. High resistance rates were noted for sulfamethoxazole/trimethoprim (78%) and tetracycline (75%), while 15.6% of the isolates showed resistance to ciprofloxacin and/or azithromycin. The <i>bla</i><sub>TEM</sub> gene encoding beta-lactamase was detected in 7/32 (22%) of isolates. Conclusions: In this study, a significant number of multidrug-resistant isolates were identified. Additionally, <i>Shigella</i> species resistant to the World Health Organization-recommended drugs call for strengthened laboratory diagnosis and close monitoring of these pathogens to guide the clinical management of shigellosis. |
|---|---|
| ISSN: | 2674-1334 |